DCF — UH ELYRIA MEDICAL CENTER
Enterprise Value: $-148.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-148.6M
Enterprise Value
$-51.0M
PV of Cash Flows
$-97.6M
PV of Terminal Value
$-157.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $212.5M | $-7.1M | -3.0% | $-16.1M | $-14.6M |
| Year 2 | $218.9M | $-5.1M | -2.0% | $-14.4M | $-11.9M |
| Year 3 | $225.5M | $-3.0M | -1.0% | $-12.5M | $-9.4M |
| Year 4 | $232.2M | $-1.9M | -1.0% | $-11.7M | $-8.0M |
| Year 5 | $239.2M | $-1.4M | -1.0% | $-11.5M | $-7.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-148.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$206.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.038250805305173115
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5